More evidence on fracture risk associated with thiazolidinediones
Two new reports have confirmed an increased risk of non-vertebral osteoporotic fractures in patients with type 2 diabetes treated with pioglitazone or rosiglitazone....
Want to read complete article? Please Sign in or Register.